GlassScriptPhysician profile
Benjamin S Abella
NPI 1568560746
$143,014.28
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $22K · 2021: $26K · 2022: $29K · 2023: $47K · 2024: $1,725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Honoraria: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500 · Travel and Lodging: $4,853 · Food and Beverage: $1,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,762.50 |
| Honoraria | $10,249.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
| Travel and Lodging | $4,853.23 |
| Food and Beverage | $1,021.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $75,688.29 | 2019-2024 | Arctic Sun 5000 |
| Zoll Circulation INC | $43,768.14 | 2020-2023 | Temperature Management System, Temperature Management System Start-Up Kit, Catheter |
| Medivance, INC. | $9,567.52 | 2019-2023 | |
| Zoll Medical Corporation | $4,714.49 | 2019-2023 | |
| Stryker Corporation | $4,450.50 | 2019-2023 | Lifepak 15 Monitor/Defibrillator |
| Tersera Therapeutics LLC | $2,125.00 | 2020 | |
| Csl Behring | $1,292.50 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,000.00 | 2022 | |
| Becton, Dickinson and Company | $223.56 | 2023 | |
| Abiomed | $150.00 | 2024 | Impella |
| Pfizer INC. | $34.28 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Abella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.